<VariationArchive VariationID="472365" VariationName="NM_004168.4(SDHA):c.1885dup (p.Tyr629fs)" VariationType="Duplication" Accession="VCV000472365" Version="18" RecordType="classified" NumberOfSubmissions="5" NumberOfSubmitters="5" DateLastUpdated="2024-05-01" DateCreated="2018-10-10" MostRecentSubmission="2024-05-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="455598" VariationID="472365">
      <GeneList>
        <Gene Symbol="SDHA" FullName="succinate dehydrogenase complex flavoprotein subunit A" GeneID="6389" HGNC_ID="HGNC:10680" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>5p15.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="218320" stop="268746" display_start="218320" display_stop="268746" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="218355" stop="256814" display_start="218355" display_stop="256814" Strand="+" />
          </Location>
          <OMIM>600857</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_004168.4(SDHA):c.1885dup (p.Tyr629fs)</Name>
      <CanonicalSPDI>NC_000005.10:254482:T:TT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>5p15.33</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="254482" stop="254483" display_start="254482" display_stop="254483" variantLength="1" positionVCF="254482" referenceAlleleVCF="C" alternateAlleleVCF="CT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="254597" stop="254598" display_start="254597" display_stop="254598" variantLength="1" positionVCF="254597" referenceAlleleVCF="C" alternateAlleleVCF="CT" />
      </Location>
      <ProteinChange>Y548fs</ProteinChange>
      <ProteinChange>Y629fs</ProteinChange>
      <ProteinChange>Y581fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004168.3" sequenceAccession="NM_004168" sequenceVersion="3" change="c.1885dupT">
            <Expression>NM_004168.3:c.1885dupT</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.10" sequenceAccession="NC_000005" sequenceVersion="10" change="g.254483dup" Assembly="GRCh38">
            <Expression>NC_000005.10:g.254483dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.9" sequenceAccession="NC_000005" sequenceVersion="9" change="g.254598dup" Assembly="GRCh37">
            <Expression>NC_000005.9:g.254598dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012339.1" sequenceAccession="NG_012339" sequenceVersion="1" change="g.41243dup">
            <Expression>NG_012339.1:g.41243dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001294332.2" sequenceAccession="NM_001294332" sequenceVersion="2" change="c.1741dup">
            <Expression>NM_001294332.2:c.1741dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001281261.1" sequenceAccession="NP_001281261" sequenceVersion="1" change="p.Tyr581fs">
            <Expression>NP_001281261.1:p.Tyr581fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001330758.2" sequenceAccession="NM_001330758" sequenceVersion="2" change="c.1642dup">
            <Expression>NM_001330758.2:c.1642dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001317687.1" sequenceAccession="NP_001317687" sequenceVersion="1" change="p.Tyr548fs">
            <Expression>NP_001317687.1:p.Tyr548fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004168.4" sequenceAccession="NM_004168" sequenceVersion="4" change="c.1885dup" MANESelect="true">
            <Expression>NM_004168.4:c.1885dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_004159.2" sequenceAccession="NP_004159" sequenceVersion="2" change="p.Tyr629fs">
            <Expression>NP_004159.2:p.Tyr629fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_315" sequenceAccession="LRG_315">
            <Expression>LRG_315:g.41243dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_315t1" sequenceAccession="LRG_315t1">
            <Expression>LRG_315t1:c.1885dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_315p1" sequenceAccession="LRG_315p1" change="p.Tyr629fs">
            <Expression>LRG_315p1:p.Tyr629fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA3173435" DB="ClinGen" />
        <XRef Type="rs" ID="750865703" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00000" Source="Trans-Omics for Precision Medicine (TOPMed)" />
        <AlleleFrequency Value="0.00001" Source="The Genome Aggregation Database (gnomAD), exomes" />
        <AlleleFrequency Value="0.00004" Source="Exome Aggregation Consortium (ExAC)" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_004168.4(SDHA):c.1885dup (p.Tyr629fs) AND multiple conditions" Accession="RCV000537063" Version="10">
        <ClassifiedConditionList TraitSetID="23694">
          <ClassifiedCondition DB="MedGen" ID="C5700310">Mitochondrial complex II deficiency, nuclear type 1</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C3279992">Paragangliomas 5</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-02-10" SubmissionCount="1">Uncertain significance</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_004168.4(SDHA):c.1885dup (p.Tyr629fs) AND not provided" Accession="RCV001555544" Version="2">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-11-11" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_004168.4(SDHA):c.1885dup (p.Tyr629fs) AND Hereditary cancer-predisposing syndrome" Accession="RCV001013539" Version="5">
        <ClassifiedConditionList TraitSetID="13598">
          <ClassifiedCondition DB="MedGen" ID="C0027672">Hereditary cancer-predisposing syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-03-21" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_004168.4(SDHA):c.1885dup (p.Tyr629fs) AND Paragangliomas 5" Accession="RCV003451192" Version="1">
        <ClassifiedConditionList TraitSetID="7580">
          <ClassifiedCondition DB="MedGen" ID="C3279992">Paragangliomas 5</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-11-27" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_004168.4(SDHA):c.1885dup (p.Tyr629fs) AND Dilated cardiomyopathy 1GG" Accession="RCV003476311" Version="1">
        <ClassifiedConditionList TraitSetID="2408">
          <ClassifiedCondition DB="MedGen" ID="C3150898">Dilated cardiomyopathy 1GG</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-07-31" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-11-27" NumberOfSubmissions="5" NumberOfSubmitters="5" DateCreated="2018-10-10" MostRecentSubmission="2024-05-01">
        <ReviewStatus>criteria provided, conflicting classifications</ReviewStatus>
        <Description>Conflicting classifications of pathogenicity</Description>
        <Explanation DataSource="ClinVar" Type="public">Pathogenic(1); Likely pathogenic(3); Uncertain significance(1)</Explanation>
        <Citation Type="general">
          <ID Source="PubMed">10721988</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12525685</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17889661</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19179534</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23043141</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23154507</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26198225</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28615448</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29483670</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29695869</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29804836</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32887801</ID>
        </Citation>
        <Comment DataSource="ClinVar" Type="public">Pathogenic(1); Likely pathogenic(3); Uncertain significance(1)</Comment>
        <DescriptionHistory Dated="2022-08-22">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2022-08-07">
          <Description>Conflicting classifications of pathogenicity</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2020-03-16">
          <Description>Uncertain significance</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="13598" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="18746" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Neoplastic Syndromes, Hereditary</ElementValue>
                <XRef ID="D009386" DB="MeSH" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary cancer-predisposing syndrome</ElementValue>
                <XRef ID="699346009" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Tumor predisposition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cancer predisposition</ElementValue>
                <XRef ID="Hereditary+Cancer/3345" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary Cancer Syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary neoplastic syndrome</ElementValue>
                <XRef ID="MONDO:0015356" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="19921" />
                <XRef ID="19921" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <Citation Type="general" Abbrev="IARC, 2008">
                <ID Source="pmc">3075918</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <XRef ID="140162" DB="Orphanet" />
              <XRef ID="C0027672" DB="MedGen" />
              <XRef ID="D009386" DB="MeSH" />
              <XRef ID="MONDO:0015356" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="2408" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="10476" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Dilated cardiomyopathy 1GG</ElementValue>
                <XRef ID="Cardiomyopathy%2C+dilated%2C+1gg/7893" DB="Genetic Alliance" />
                <XRef ID="MONDO:0013339" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CMD1GG</ElementValue>
                <XRef Type="MIM" ID="613642" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15684" />
                <XRef ID="15684" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="154" DB="Orphanet" />
              <XRef ID="C3150898" DB="MedGen" />
              <XRef ID="MONDO:0013339" DB="MONDO" />
              <XRef Type="MIM" ID="613642" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="7580" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16481" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">PHEOCHROMOCYTOMA/PARAGANGLIOMA SYNDROME 5</ElementValue>
                <XRef Type="MIM" ID="614165" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600857.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600857.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600857.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600857.0008" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Paragangliomas 5</ElementValue>
                <XRef ID="Paragangliomas+5/9075" DB="Genetic Alliance" />
                <XRef ID="MONDO:0013602" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PPGL5</ElementValue>
                <XRef Type="MIM" ID="614165" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PGL5</ElementValue>
                <XRef Type="MIM" ID="614165" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15763" />
                <XRef ID="15763" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Hereditary paraganglioma-pheochromocytoma (PGL/PCC) syndromes are characterized by paragangliomas (tumors that arise from neuroendocrine tissues distributed along the paravertebral axis from the base of the skull to the pelvis) and pheochromocytomas (paragangliomas that are confined to the adrenal medulla). Sympathetic paragangliomas cause catecholamine excess; parasympathetic paragangliomas are most often nonsecretory. Extra-adrenal parasympathetic paragangliomas are located predominantly in the skull base and neck (referred to as head and neck PGL [HNPGL]) and sometimes in the upper mediastinum; approximately 95% of such tumors are nonsecretory. In contrast, sympathetic extra-adrenal paragangliomas are generally confined to the lower mediastinum, abdomen, and pelvis, and are typically secretory. Pheochromocytomas, which arise from the adrenal medulla, typically lead to catecholamine excess. Symptoms of PGL/PCC result from either mass effects or catecholamine hypersecretion (e.g., sustained or paroxysmal elevations in blood pressure, headache, episodic profuse sweating, forceful palpitations, pallor, and apprehension or anxiety). The risk for developing metastatic disease is greater for extra-adrenal sympathetic paragangliomas than for pheochromocytomas.</Attribute>
                <XRef ID="NBK1548" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301715</ID>
                <ID Source="BookShelf">NBK1548</ID>
              </Citation>
              <Citation Type="general" Abbrev="ES, 2014">
                <ID Source="PubMed">24893135</ID>
              </Citation>
              <XRef ID="29072" DB="Orphanet" />
              <XRef ID="C3279992" DB="MedGen" />
              <XRef ID="MONDO:0013602" DB="MONDO" />
              <XRef Type="MIM" ID="614165" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="23694" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5546" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Mitochondrial complex II deficiency</ElementValue>
                <XRef ID="Mitochondrial+complex+II+deficiency/4824" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Complex 2 mitochondrial respiratory chain deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Succinate CoQ reductase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Mitochondrial complex II deficiency, nuclear type 1</ElementValue>
                <XRef ID="MONDO:0100294" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5053" />
                <XRef ID="5053" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="3208" DB="Orphanet" />
              <XRef ID="C5700310" DB="MedGen" />
              <XRef ID="MONDO:0100294" DB="MONDO" />
              <XRef Type="MIM" ID="252011" DB="OMIM" />
            </Trait>
            <Trait ID="16481" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">PHEOCHROMOCYTOMA/PARAGANGLIOMA SYNDROME 5</ElementValue>
                <XRef Type="MIM" ID="614165" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600857.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600857.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600857.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600857.0008" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Paragangliomas 5</ElementValue>
                <XRef ID="Paragangliomas+5/9075" DB="Genetic Alliance" />
                <XRef ID="MONDO:0013602" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PPGL5</ElementValue>
                <XRef Type="MIM" ID="614165" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PGL5</ElementValue>
                <XRef Type="MIM" ID="614165" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15763" />
                <XRef ID="15763" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Hereditary paraganglioma-pheochromocytoma (PGL/PCC) syndromes are characterized by paragangliomas (tumors that arise from neuroendocrine tissues distributed along the paravertebral axis from the base of the skull to the pelvis) and pheochromocytomas (paragangliomas that are confined to the adrenal medulla). Sympathetic paragangliomas cause catecholamine excess; parasympathetic paragangliomas are most often nonsecretory. Extra-adrenal parasympathetic paragangliomas are located predominantly in the skull base and neck (referred to as head and neck PGL [HNPGL]) and sometimes in the upper mediastinum; approximately 95% of such tumors are nonsecretory. In contrast, sympathetic extra-adrenal paragangliomas are generally confined to the lower mediastinum, abdomen, and pelvis, and are typically secretory. Pheochromocytomas, which arise from the adrenal medulla, typically lead to catecholamine excess. Symptoms of PGL/PCC result from either mass effects or catecholamine hypersecretion (e.g., sustained or paroxysmal elevations in blood pressure, headache, episodic profuse sweating, forceful palpitations, pallor, and apprehension or anxiety). The risk for developing metastatic disease is greater for extra-adrenal sympathetic paragangliomas than for pheochromocytomas.</Attribute>
                <XRef ID="NBK1548" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301715</ID>
                <ID Source="BookShelf">NBK1548</ID>
              </Citation>
              <Citation Type="general" Abbrev="ES, 2014">
                <ID Source="PubMed">24893135</ID>
              </Citation>
              <XRef ID="29072" DB="Orphanet" />
              <XRef ID="C3279992" DB="MedGen" />
              <XRef ID="MONDO:0013602" DB="MONDO" />
              <XRef Type="MIM" ID="614165" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="3491096" SubmissionDate="2021-08-10" DateLastUpdated="2021-08-13" DateCreated="2021-08-13">
        <ClinVarSubmissionID localKey="GDXSV:23577" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV001776982" DateUpdated="2021-08-13" DateCreated="2021-08-13" Type="SCV" Version="1" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-11-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>Frameshift variant predicted to result in protein truncation and affect the functionally important C-terminal region, as the last 36 amino acids are lost and replaced with 13 incorrect amino acids, and other loss-of-function variants have been reported downstream in the Human Gene Mutation Database (Kim 2012, Stenson 2014); Not observed at a significant frequency in large population cohorts (Lek 2016); Has not been previously published as pathogenic or benign to our knowledge</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SDHA" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:1604397</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004168.2:c.1885dupT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_21_20210809104732</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7827837" SubmissionDate="2023-12-21" DateLastUpdated="2023-12-24" DateCreated="2023-12-24">
        <ClinVarSubmissionID localKey="101777262|OMIM:614165" />
        <ClinVarAccession Accession="SCV004189646" DateUpdated="2023-12-24" DateCreated="2023-12-24" Type="SCV" Version="1" SubmitterName="Myriad Genetics, Inc." OrgID="507240" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>This variant is considered likely pathogenic. This variant creates a frameshift predicted to result in premature protein truncation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Myriad Autosomal Dominant, Autosomal Recessive and X-Linked Classification Criteria (2023)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/8ufcwsf2/myriad_genetics_classification_criteria_2023.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SDHA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="hg19" Chr="5" alternateAllele="TT" referenceAllele="T" start="254598" stop="254598" />
          </Location>
          <OtherNameList>
            <Name Type="SubmitterVariantId">101777262</Name>
          </OtherNameList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="614165" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14104645</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7853253" SubmissionDate="2023-12-07" DateLastUpdated="2023-12-30" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_004168.4:c.1885dup|OMIM:613642" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004200609" DateUpdated="2023-12-30" DateCreated="2023-12-30" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-07-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004168.4:c.1885dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="613642" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1249596" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2017-12-26">
        <ClinVarSubmissionID localKey="709944|MedGen:C3279992;C1855008" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000651416" DateUpdated="2024-02-28" DateCreated="2017-12-26" Type="SCV" Version="8" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-02-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Comment>This sequence change creates a premature translational stop signal (p.Tyr629Leufs*14) in the SDHA gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 36 amino acid(s) of the SDHA protein. This variant is present in population databases (rs750865703, gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with paraganglioma and pheochromocytoma (Invitae). ClinVar contains an entry for this variant (Variation ID: 472365). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SDHA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000005.9:g.254597_254598insT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3279992" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1855008" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">28492532</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2314129" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2020-03-16">
        <ClinVarSubmissionID localKey="a828805|MedGen:C0027672" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001174138" DateUpdated="2024-05-01" DateCreated="2020-03-16" Type="SCV" Version="5" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-03-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10721988</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12525685</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17889661</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19179534</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23043141</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23154507</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26198225</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28615448</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29483670</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29695869</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29804836</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32887801</ID>
          </Citation>
          <Comment>The c.1885dupT pathogenic mutation, located in coding exon 14 of the SDHA gene, results from a duplication of T at nucleotide position 1885, causing a translational frameshift with a predicted alternate stop codon (p.Y629Lfs*14). This alteration occurs at the 3' terminus of theSDHA gene, is not expected to trigger nonsense-mediated mRNA decay, and only impacts the last 36 amino acids of the protein. However, premature stop codons are typically deleterious in nature, the impacted region is critical for protein function, and a significant portion of the protein is affected (Ambry internal data). In addition, this alteration has been detected in multiple individuals with a paraganglioma (Ambry internal data). Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SDHA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004168.2:c.1885dupT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0027672" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>All AVA3 Novel and Update Variants_103122</SubmissionName>
          <SubmissionName>FinalAVA3AVA4ClinvarDepositThrough061523</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
          <SubmissionName>NonExomeUpdate_081220AmbryReport</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3491096" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7827837" TraitType="Disease" MappingType="XRef" MappingValue="614165" MappingRef="OMIM">
        <MedGen CUI="C3279992" Name="Paragangliomas 5" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7853253" TraitType="Disease" MappingType="XRef" MappingValue="613642" MappingRef="OMIM">
        <MedGen CUI="C3150898" Name="Dilated cardiomyopathy 1GG" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2314129" TraitType="Disease" MappingType="XRef" MappingValue="C0027672" MappingRef="MedGen">
        <MedGen CUI="C0027672" Name="Hereditary cancer-predisposing syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1249596" TraitType="Disease" MappingType="XRef" MappingValue="C3279992" MappingRef="MedGen">
        <MedGen CUI="C3279992" Name="Paragangliomas 5" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1249596" TraitType="Disease" MappingType="XRef" MappingValue="C1855008" MappingRef="MedGen">
        <MedGen CUI="C5700310" Name="Mitochondrial complex II deficiency, nuclear type 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

